6533b7d6fe1ef96bd12659ea
RESEARCH PRODUCT
Role of PD-L1 expression in triple-negative breast cancer stem cells.
Giovanna TalaricoSerenella M. PupaMario P. ColomboSabina SangalettiLorenzo CastagnoliClaudio TripodoSimona FaraciMarilena V. IorioElda TagliabueSandra RomeroTatiana VolpariGiovanni FucàValeria CancilaFilippo De BraudMassimo Di NicolaClaudia Chiodonisubject
Cancer ResearchPoor prognosisOncologybusiness.industryCancer researchMedicinePd l1 expressionStem cellbusinessTriple-negative breast cancerImmune checkpointdescription
12081Background: Triple negative breast cancer (TNBC) is characterized by poor prognosis, lack of specific-targeted agents and is in need of new therapeutics. Immune checkpoint blockers have shown ...
year | journal | country | edition | language |
---|---|---|---|---|
2018-05-20 | Journal of Clinical Oncology |